






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Campbelletal. 2011 USA 147 CAM Cognition SPMSQ















McAvayetal. 2007 USA 416 CAM Depression GDS
O’Keeffeand
Lavan














































































































































































































































































































































































































 Delirium NoDelirium   



























4.21 .070 98 .94































 Delirium NoDelirium   
Study Mean SD Mean SD t df p
Francoetal.(2010) 20.65 4.65 24.23 4.01 4.276 289 <.001
Wakefield(1996&2002) 22.10 4.3 25.20 3.5 Ͳ3.14 115 <.005
Wilson(2005) 22.75 3.39 26.35 3.58 Ͳ3.29 98 .001



































Cognitiveimpairmentdiagnosis 2 12 >.99
Abnormalmini–cogscore 13 32 .004

















































 Delirium NoDelirium   
Study Mean SD Mean SD t df p
McAvayetal(2007) 9.7 3.8 11.1  3.7 NA NA .01
Francoetal(2010) 4.26 3.36 5.10 4.48 NA NA NA
Jonesetal(2006) 9.4 3.9 11.2 3.7 NA NA <.001









































































 Delirium NoDelirium   
Study Mean SD Mean SD t df p
McAvayetal(2007) 3.1 2.2 2.6 2.1 NA NA .20
Campbelletal(2011) 2.4 1.9 3.1 2.3 NA NA .13





























































































































































Meanage(SD) 84.11(7.4) 77.69(11.8) 83.98(7.6)
Gender   
Female 94(58.4) 172(53.6) 25(52.1)
Male 67(41.6) 149(46.4) 23(47.9)
Livingstatusonadmission   
Homealone 49(30.4) 86(26.8) 9(18.8)
Homewithservices 9(5.6) 14(4.4) 1(2.1)
Livingwithfamily 72(44.7) 178(55.5) 26(54.2)
Lowlevelcare 18(11.2) 27(8.4) 8(16.7)
Highlevelcare 13(8.1) 16(5.0) 4(8.3)
Leveloffunctioning   







Fullassistancerequired(Katzscore0) 14(8.7) 5(1.6) 1(2.1)
Reportedcognitiononadmission   
Cognitionreportedasnormal 76(47.2) 246(76.6) 21(43.8)
Reportedcognitiveissues(nodiagnosis) 13(8.1) 6(1.9) 4(8.3)
Mildcognitiveimpairment 6(3.7) 0 2(4.2)
Somememoryloss 40(24.8) 49(15.3) 13(27.1)
Dementia 26(16.1) 20(6.2) 8(16.7)
Fallshistory(priortoadmission)   
Nofalls 48(29.8) 186(57.9) 19(39.6)
Lessthan2in6months 77(47.8) 111(34.6) 22(45.8)
Morethan2in6months 32(19.9) 24(7.5) 7(14.6)
Nodata 4(2.5) 0 0
Pressureriskscore(onadmission)   
Low 90(55.9) 222(69.2) 25(52.1)
Medium 47(29.2) 61(19.0) 12(25.0)
High 21(13.0) 31(9.7) 10(20.8)





































































AbdominalPain 2(1.2) 1(0.3) 0 0 3(0.9) 0
AllergicReaction 0 4(1.2) 0 0 0 0
Anaemia 5(3.1) 5(1.6) 0 1(0.6) 1(0.3) 1(2.1)
BackPain 2(1.2) 17(5.3) 4(8.3) 1(0.6 5(1.6) 0
CarAccident 0 2(0.6) 0 0 0 0
CardiacAF 4(2.5) 10(3.1) 0 0 0 0
CardiacCCF 10(6.2) 24(7.5) 2(4.2) 2(1.2) 7(2.2) 1(2.1)
CardiacMI 4(2.5) 11(3.4) 2(4.2) 5(3.1) 14(4.4) 1(2.1)
CardiacOther 0 1(0.3) 0 0 0 0
Cellulitis 3(1.9) 12(3.7) 1(2.1) 1(0.6) 6(1.9) 1(2.1)
Collapse 19(11.8) 11(3.4) 5(10.4) 1(0.6) 4(1.2) 0
Constipation 2(1.2) 3(0.9) 0 0 0 0
Dehydration 0 0 0 1(0.6) 1(0.3) 1(2.1)
Dizziness/Vertigo 0 1(0.3) 0 0 1(0.3) 1(0.3)
DiabeticIssue 1(0.6) 2(0.6) 0 0 6(1.9) 0
ElectrolyteImbalance 1(0.6) 5(1.6) 0 6(3.7) 3(0.9) 0
Fall 48(29.8) 51(15.9) 17(35.4) 3(1.9) 2(0.6) 0
Fracture 3(1.9) 3(0.9) 0 27(16.8) 28(8.7) 10(20.8)
GeneralisedWeakness 1(0.6) 4(1.2) 2(4.2) 2(1.2) 5(1.6) 1(2.1)
Gastrointestinal
Obstruction
0 2(0.6) 1(2.1) 0 0 0
Haematoma 1(0.6) 0 2(4.2) 0 3(0.9) 0
Infection/sepsis 1(0.6) 8(2.5) 1(2.1) 3(1.9) 5(1.6) 0
Leukaemia 0 0 0 0 1(0.3) 0
MedicationRelated 0 1(0.3) 0 0 0 0
Pain 4(2.5) 8(2.5) 0 0 13(4.0) 1(2.1)
RespiratoryExacerbation 4(2.5) 19(5.9) 2(4.2) 0 3(0.9) 0
RenalFailure 2(1.2) 7(2.2) 0 8(5.0) 13(4.0) 2(4.2)
RespiratoryInfection 29(18.0) 58(18.1) 5(10.4) 12(7.5) 12(3.7) 6(12.5)
ReducedMobility 1(0.6) 1(0.3) 1(2.1) 0 0 0
RespiratoryEffusion 1(0.6) 4(1.2) 0 0 0 0
RespiratoryEmbolism 0 3(0.9) 0 0 1(0.3) 0
Seizure 0 1(0.3) 0 0 1(0.3) 0
Stroke 2(1.2) 11(3.4) 1(2.1) 3(1.9) 1(0.3) 1(2.1)
UrinaryInfection 6(3.7) 9(2.8) 1(2.1) 7(4.3) 9(2.8) 4(8.3)
UrineRetention 1(0.6) 2(0.6) 0 0 1(0.3) 0
Vomit/Diarrhoea 4(2.5) 17(5.3) 1(2.1) 4(2.5) 3(0.9) 0
WeightLoss 0 0 0 0 2(0.6) 0













































OddsRatio(95%CI) df Pearson’sF2value p

Age>80years 124(77.0) 178(55.5) 2.69(1.75–4.13) 1 20.40 .00
Anaemia 6(3.7) 13(4.0) 1.09(0.41–2.92) 1 0.00 1.0
Cancer 21(13.0) 44(13.7) 0.94(0.54–1.65) 1 .004 .95
CognitiveImpairment 61(37.9) 54(16.8) 3.01(1.96–4.65) 1 25.05 .00
COAD 27(16.8) 77(24.0) 1.57(0.96–2.55) 1 2.89 .09
Depression 35(21.7) 53(16.5) 1.41(0.87–2.26) 1 1.63 .20
Dementia 26(16.1) 20(6.2) 2.90(1.56–5.37) 1 11.10 .001
Diabetes 40(24.8) 72(22.4) 0.86(0.56–1.36) 1 0.23 .63
FunctionalImpairment 71(44.1) 66(20.6) 3.05(2.02–4.60) 1 28.06 .00
FallonAdmission 51(31.7) 53(16.5) 2.34(1.50–3.65) 1 13.70 .00
FractureonAdmission 29(18.0) 31(9.7) 2.06(1.19–3.55) 1 6.12 .013
Gender(Male) 67(41.6) 149(46.4) 0.82(0.56–1.21) 1 0.82 .37
HearingImpairment 30(18.6) 48(15.0) 1.30(0.79–2.15) 1 0.82 .37
Hypertension 92(57.1) 185(57.6) 1.02(0.70–1.49) 1 0.00 .99
Hypercholesterolemia 54(33.5) 76(23.7) 1.61(1.08–2.44) 1 4.81 .03
IschemicHeartDisease 28(17.4) 51(15.9) 0.90(0.54–1.49) 1 0.08 .77
JointReplacement 22(13.7) 27(8.4) 1.72(0.95–3.13) 1 2.70 .10
Osteoporosis 59(36.6) 87(27.1) 0.64(0.43–0.96) 1 4.18 .04
Parkinson’sDisease 12(7.5) 9(2.8) 2.79(1.15Ͳ6.76) 1 4.50 .03
PreviousDelirium 16(9.9) 2(0.6) 17.54(3.99–77.55) 1 23.35 .00
RecentAdmissiontoHospital 59(36.6) 137(42.7) 0.77(0.53–1.15) 1 1.37 .24
RenalFailure 19(11.8) 34(10.6) 1.13(0.62–2.05) 1 0.06 .81
StrokeorTIA 38(23.6) 38(11.8) 2.30(1.40–3.78) 1 10.31 .001

















































Age>80years 39(81.3) 178(55.5) 3.48(0.63–7.43) 1 10.43 .001
Anaemia 2(4.2) 13(4.0) 0.97(0.21–4.44) 1 .00 1.00
Cancer 10(20.8) 44(13.7) 0.60(0.28–1.30) 1 1.18 .28
CognitiveImpairment 19(39.6) 54(16.8) 3.22(1.69–6.25) 1 12.24 .00
COAD 7(14.6) 77(24.0) 1.85(0.80–4.29) 1 1.60 .21
Dementia 8(16.7) 20(6.2) 3.03(1.25–7.14) 1 5.08 .02
Depression 10(20.8) 53(16.5) 0.75(0.35–1.60) 1 0.29 .59
Diabetes 10(20.8) 72(22.4) 1.10(0.52–2.31) 1 .004 .95
FunctionalImpairment 26(54.2) 66(20.6) 4.55(2.44–8.33) 1 23.43 .00
FallonAdmission 17(35.4) 53(16.5) 2.77(1.43–5.26) 1 8.52 .004
FractureonAdmission 10(20.8) 31(9.7) 2.44(1.12–5.26) 1 4.21 .04
Gender(Male) 23(47.9) 149(46.4) 0.94(0.51–1.73) 1 0.002 .97
HearingImpairment 10(20.8) 48(15.0) 0.67(0.31–1.43) 1 0.69 .41
Hypertension 33(68.8) 185(57.6) 0.62(0.32–1.18) 1 1.70 .19
Hypercholesterolemia 17(35.4) 76(23.7) 0.57(0.30–1.08) 1 2.46 .12
IschemicHeartDisease 11(22.9) 51(15.9) 0.64(0.30Ͳ1.33) 1 1.02 .31
JointReplacement 3(6.3) 27(8.4) 1.38(0.40–4.73) 1 .05 .82
Osteoporosis 10(20.8) 87(27.1) 1.41(0.68–2.96) 1 .55 .46
Parkinson’sDisease 1(2.1) 9(2.8) 1.36(0.17–10.95) 1 .00 1.00
RecentAdmissiontoHospital 19(39.6) 137(42.7) 1.14(0.61–2.11) 1 0.06 .80
RenalFailure 5(10.4) 34(10.6) 1.02(0.38–2.75) 1 0.00 1.00
StrokeorTIA 9(18.8) 38(11.8) 0.58(0.26–1.30) 1 1.23 .27













































Age .040 .013 9.08 1 .003 1.04 1.01 1.07
CognitiveImpairment .941 .254 13.76 1 .000 2.56 1.56 4.21
Dementia 1.016 .372 7.45 1 .006 2.76 1.33 5.73
FunctionalImpairment .603 .259 5.42 1 .020 1.83 1.10 3.04
Fall .365 .301 1.47 1 .225 1.44 .80 2.60
Fracture .676 .372 3.30 1 .069 1.97 .95 4.08
Hypercholesterolemia .533 .250 4.55 1 .033 1.70 1.04 2.783
Osteoporosis .023 .240 .009 1 .924 1.02 .64 1.64
PreviousDelirium 2.701 .786 11.80 1 .001 14.9 3.19 69.55
Parkinson’s .480 .550 .76 1 .383 1.62 .55 4.75
StrokeorTIA .548 .288 3.62 1 .057 1.73 .98 3.04
VisionImpairment .354 .293 1.46 1 .227 1.43 .80 2.53


















Age .04 .01 10.18 1 .001 1.04 1.02 1.07
CognitiveImpairment .97 .25 14.81 1 .000 2.63 1.61 4.32
Dementia .99 .37 7.26 1 .007 2.70 1.31 5.54
Fracture .90 .31 8.31 1 .004 2.46 1.33 4.53
FunctionalImpairment .70 .25 7.57 1 .006 2.01 1.22 3.29
Hypercholesterolemia .54 .25 4.67 1 .031 1.71 1.05 2.77
PreviousDelirium 2.80 .78 12.96 1 .000 16.48 3.57 75.07
StrokeorTIA .52 .29 3.31 1 .069 1.69 .96 2.97










































AgeGreaterthan80 Ͳ.335 .249 1.806 1 .179 .72 .44 1.17
CognitiveImpairment 1.029 .254 16.389 1 .000 2.80 1.70 4.61
Dementia 1.088 .371 8.575 1 .003 2.97 1.43 6.15
Fall .396 .301 1.735 1 .188 1.49 .82 2.68
FunctionalImpairment .712 .255 7.789 1 .005 2.04 1.24 3.36
Fracture .698 .372 3.519 1 .061 2.01 .97 4.17
Hypercholesterolemia .526 .248 4.483 1 .034 1.69 1.04 2.75
Osteoporosis .121 .237 .263 1 .608 1.13 .71 1.80
Parkinson’s .359 .544 .436 1 .509 1.43 .49 4.15
PreviousDelirium 2.748 .788 12.150 1 .000 15.62 3.33 73.25
StrokeOrTIA .621 .286 4.708 1 .030 1.86 1.06 3.26
VisionImpairment .404 .295 1.881 1 .170 1.50 .84 2.68













CognitiveImpairment 1.139 .247 21.234 1 .000 3.12 1.92 5.07
Dementia 1.138 .366 9.672 1 .002 3.12 1.52 6.40
Fracture 1.009 .308 10.720 1 .001 2.74 1.50 5.02
FunctionalImpairment .863 .247 12.247 1 .000 2.37 1.46 3.84
Hypercholesterolemia .538 .245 4.795 1 .029 1.71 1.06 2.77
PreviousDelirium 2.928 .777 14.185 1 .000 18.69 4.07 85.79
StrokeorTIA .640 .284 5.082 1 .024 1.90 1.09 3.31
























































72(44.7) 101(31.5) 1.76(1.19Ͳ2.60) 1 7.62 .006
Administered
Benzodiazepines
74(46.0) 114(35.5) 1.55(1.05Ͳ2.27) 1 4.49 .034
Addmorethan3
Medications
85(52.8) 71(22.1) 3.94(2.62Ͳ5.91) 1 44.70 .000
MovedWards 39(24.2) 58(18.1) 1.44(0.92Ͳ2.29) 1 2.58 .142
UseofIDC 57(35.4) 60(18.7) 2.38(1.55Ͳ3.66) 1 15.40 .000








































AbnormalSodium 24(50) 101(31.5) 2.18(1.18Ͳ4.02) 1 5.60 .02
Addmorethan3
Medications
24(50) 71(22.1) 3.52(1.89Ͳ6.57) 1 15.55 <.00
Administered
Benzodiazepines
21(43.8) 114(35.5) 1.41(0.76Ͳ2.61) 1 0.89 .35
MovedWards 14(29.2) 58(18.1) 1.87(0.94Ͳ3.70) 1 2.61 .11
UseofIDC 17(35.4) 60(18.7) 2.39(1.24Ͳ4.59) 1 6.10 .01




















































SodiumLevelOA 137.46(5.3) 137.26(4.5) 480 0.43 0.20(Ͳ0.71Ͳ1.11) .67
SodiumLevelDay3 137.23(12.1) 135.40(19.3) 472 1.09 1.83(Ͳ1.47–5.12) .28
UreaLevelOA 10.70(7.6) 9.99(9.7) 480 0.81 0.71(Ͳ1.01–2.42) .42




























AbnormalSodium Ͳ.398 .214 3.451 1 .063 1.49 0.99 2.27
AdministeredBenzodiazepine Ͳ.245 .214 1.319 1 .251 1.28 0.84 1.94
Addmorethan3Medications Ͳ1.226 .214 32.825 1 .000 3.40 2.24 5.18
IDC Ͳ.629 .238 7.016 1 .008 1.88 1.18 2.99
UreaDay3 .020 .017 1.379 1 .240 0.98 0.95 1.01



















IDC .694 .232 8.958 1 .003 2.00 1.27 3.15
Addmorethan3Medications 1.274 .212 36.279 1 .000 3.58 2.36 5.41
AbnormalSodium .430 .212 4.118 1 .042 1.54 1.02 2.33

















































































AnotherAcuteFacility 0 0 0 4(2.5) 15(4.7) 1(2.1)
Died 0 0 0 9(5.6) 10(3.1) 6(12.5)
HomeAlone 49(30.4) 86(26.8) 9(18.8) 3(1.9) 34(10.6) 1(2.1)
HomewithServices 9(5.6) 14(4.4) 1(2.1) 11(6.8) 28(8.7) 1(2.1)
HomewithFamily 72(44.7) 178(55.5) 26(54.2) 29(18.0) 112(34.9) 11(22.9)
HLC 13(8.1) 16(5.0) 4(8.3) 13(8.1) 16(5.0) 4(8.3)
LLC 18(11.2) 27(8.4) 8(16.7) 10(6.2) 19(5.9) 4(8.3)
PalliativeCare 0 0 0 5(3.1) 1(0.3) 3(6.3)
Rehabilitation 0 0 0 68(42.2) 79(24.6) 17(35.4)






























Changeincontinence 67(41.6) 8(2.5) 27.88(12.93Ͳ60.14) 1 121.95 .00
Codegrey 22(13.7) 1(0.3) 50.6(6.76Ͳ379.47) 1 39.19 .00
Decreasedfunctioning 72(44.7) 28(8.7) 8.47(5.15Ͳ13.91) 1 82.33 .00
Developedpressureinjury 5(3.1) 1(0.3) 10.26(1.19Ͳ88.54) 1 4.73 .02
Diedduringadmission 9(5.6) 10(3.1) 1.84(0.73Ͳ4.63) 1 1.14 .29
Diedafteradmission 30(18.6) 36(11.2) 1.81(1.07Ͳ3.07) 1 4.39 .04
Dischargedtocarefacility 37(23.0) 43(13.4) 1.93(1.18Ͳ3.14) 1 6.44 .01
Dischargedto
rehabilitation
68(42.2) 79(24.6) 2.24(1.50Ͳ3.36) 1 14.89 .00
Fall 27(16.8) 11(3.4) 5.68(2.74Ͳ11.78) 1 24.48 .00









































Changeincontinence 16(33.3) 8(2.5) 19.56(7.77–49.25) 1 60.34 <.00
Diedduringadmission 6(12.5) 10(3.1) 4.44(1.54–12.85) 1 6.75 .01
Diedafteradmission 10(20.8) 36(11.2) 2.08(0.96–4.54) 1 2.71 .10
Decreasedfunctioning 14(29.2) 28(8.7) 4.31(2.07–8.97) 1 15.34 <.00
Dischargedtocare
facility
11(22.9) 43(13.4) 1.92(0.91–4.05) 1 2.32 .13
Dischargedto
rehabilitation
17(35.4) 79(24.6) 1.68(0.88–3.20) 1 2.00 .16
Fall 8(16.7) 11(3.4) 8.54(2.14Ͳ14.93) 1 12.40 <.00





























































































































































































ChangeinContinence Ͳ2.979 .421 50.046 1 .000 .051 .022 .116
DischargedtoRehabilitation Ͳ.035 .317 .012 1 .913 .966 .519 1.798
DischargedtoCareFacility Ͳ.919 .320 8.237 1 .004 .399 .213 .747
DiedafterAdmission Ͳ.134 .350 .146 1 .702 .875 .440 1.738
DeclineinFunction Ͳ1.568 .348 20.336 1 .000 .208 .105 .412
Fall 1.200 .452 7.066 1 .008 3.321 1.371 8.046
LengthofStay Ͳ.015 .022 .498 1 .480 .985 .944 1.027

















DeclineinFunction Ͳ1.528 .299 26.154 1 .000 4.61 2.56 8.26
DischargedtoCareFacility Ͳ.892 .297 9.028 1 .003 2.44 1.36 4.37
Fall 1.175 .446 6.944 1 .008 3.24 1.35 7.77
Incontinence Ͳ2.931 .411 50.808 1 .000 18.87 8.40 41.67











































































































































































































































































































Alprazolam 5(3.1) 5(1.5) 0
Clonazepam 1(0.6) 3(0.9) 0
Diazepam 5(3.1) 14(4.4) 2(4.2)
Lorazepam 0 4(1.2) 0
Nitrazepam 2(1.2) 4(1.2) 0
Oxazepam 6(3.7) 18(5.6) 2(4.2)
Temazepam 13(8.1) 36(11.2) 7(14.6)




























Alprazolam 2(1.2) 3(0.9) 0
Clonazepam 2(1.2) 0 0
Diazepam 11(6.8) 11(3.4) 6(12.5)
Lorazepam 3(1.9) 4(1.2) 0
Midazolam 10(6.2) 1(0.3) 3(6.25)
Nitrazepam 1(0.6) 0 0
Oxazepam 7(4.3) 3(0.9) 0

















































































Noenvironmentalstrategies 130(80.7) 312(97.2) 42(87.5)
Encouragefamilyinvolvement 19(11.8) 3(0.9) 1(2.1)
Provisionofasingleroom 13(8.1) 6(1.9) 4(8.3)
Avoidroomchanges 1(0.6) 0 0
Quietenvironment 1(0.6) 0 1(2.1)





























Encouragementoffoodandfluidintake 103(64.0) 117(36.4) 22(45.8)




Painmanagement 28(17.4) 51(15.9) 6(12.5)
Regulationofbowelfunction 20(12.4) 14(4.4) 2(4.1)
Ensuringpatientwearshearingaids 10(6.2) 12(3.7) 2(4.1)
Encourageandestablishasleeproutine 2(1.2) 2(0.6) 0
Encourageindependence 1(0.6) 3(0.9) 1(2.1)
Medicationreview 1(0.6) 0 1(2.1)

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































cognitiveimpairment F Abnormalserumsodium F
Depression F UseofanIDCduringadmission F
Visualimpairment F Useofphysicalrestraints F
Previousepisodeofdelirium F Severemedicalillness F
Hearingimpairment F Adding>3medicationsduringhospitalisation F
Functionalimpairment


















































































































































































































































































































































































































































































































































PLAIN LANGUAGE STATEMENT  
Plain Language Statement
Date:
Full Project Title: Incident delirium in acute medical patients  
Principal Researcher: Alison Hutchinson 
Student Researcher: Emily Cull 
Associate Researcher(s): Nikki Philips 
Dear Director of Nursing,  
This letter is to invite you to participate in a research project, which examines the policies 
and procedures used in health-care organisations for patients with delirium. This will help to 
provide information regarding how delirium is managed in hospitals and the process of care 
that is recommended for these patients. The project is being undertaken as part of a PhD 
degree.
You have been selected as a potential respondent at this organisation. We are seeking a 
respondent who has a good understanding of policies used in the organisation and the 
content of these policies. Whether you agree to take part in the project is completely up to 
you. If you are not able to participate in the study we ask you to forward the attached plain 
language statement to a person who think would be suitable.  
This study will involve completing a questionnaire regarding policies and procedures for 
delirium management. The questionnaire is anonymous and will only require stating the 
respondent’s position in the organisation. It should take around 5 – 10 minutes of your time 
to complete. Surveys are being sent to all public and private hospitals in Melbourne for 
potential participation. If you agree to participate, please return your questionnaire by [date]. 
Implied consent is obtained via the completion of the survey. Surveys can be returned by 
email (from a generic and non-identifiable email address), by post, or respondents can 
arrange to have the survey completed over the phone.  
Participants are invited to contact the researchers should they wish to obtain a summary of 






The ethical aspects of this research project have been approved by a human ethics panel at 
Deakin University. If you have any complaints about any aspect of the project, the way it is 
being conducted or any questions about your rights as a research participant, then you may 
contact:  
The Manager, Office of Research Integrity, Level 1, Building EA, Deakin University, Elgar 
Road, Burwood Victoria 3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-
ethics@deakin.edu.au.  
Please quote project number  
If you require further information, wish to withdraw your participation or if you have any 
problems concerning this project, you can contact the research supervisor.  

































PLAIN LANGUAGE STATEMENT  
Plain Language Statement
Date:
Full Project Title: Incident delirium in acute medical patients  
Principal Researcher: Alison Hutchinson 
Student Researcher: Emily Cull 
Associate Researcher(s): Nikki Philips 
Dear potential respondent,  
This letter is to invite you to participate in a research project which examines the policies and 
procedures used in health-care organisations for patients with delirium. This will help to 
provide information regarding how delirium is managed in hospitals and the process of care 
that is recommended for these patients. The project is being undertaken as part of a PhD 
degree.
You have been identified as a potential respondent at this organisation by the director of 
nursing and is someone who has a good understanding of delirium management policies 
used by the organisation and the content of these policies. Whether you agree to take part in 
the project is completely up to you.  
This study will involve completing a questionnaire regarding policies and procedures for 
delirium management. The questionnaire is anonymous and will only require stating your 
position in the organisation (e.g NUM). It should take around 5 – 10 minutes of your time to 
complete. Surveys are being sent to all public and private hospitals in Melbourne for 
potential participation. If you agree to participate, please return your questionnaire by [date]. 
Implied consent is obtained via the completion of the survey. You may return the survey by 
email (from a generic and non-identifiable email address), by post, or you can arrange to 
have the survey completed over the phone.  
Participants are invited to contact the researchers should they wish to obtain a summary of 
the results.  
The ethical aspects of this research project have been approved by a human ethics panel at 
Deakin University. If you have any complaints about any aspect of the project, the way it is 







The Manager, Office of Research Integrity, Level 1, Building EA, Deakin University, Elgar 
Road, Burwood Victoria 3125, Telephone: 9251 7129, Facsimile: 9244 6581; research-
ethics@deakin.edu.au.   Please quote project number  
If you require further information, wish to withdraw your participation or if you have any 
problems concerning this project, you can contact the research supervisor.  
Thank you for your time. 
Emily Cull 
PhD Candidate  
Deakin University 
ejcull@deakin.edu.au
































































































































































































































































































































































































































































































































































































































































9 Wasappropriatestatisticalanalysisused? Yes Fisherexacttestandanalysisof
varianceusedtocomparedata.




































































8 Wereoutcomesmeasuredinareliableway? Yes Alloutcomesweremeasured
usingvalidtoolssuchasMMSE,
CAMandDRSͲR98
9 Wasappropriatestatisticalanalysisused? Yes MannͲWhitneytest.Ttestsand
chiͲsquaresusedtoevaluate
differences.






































































8 Wereoutcomesmeasuredinareliableway? Yes Alloutcomesweremeasured
usingvalidtoolsincluding
APACHE,MMSE,CAM.
9 Wasappropriatestatisticalanalysisused? Yes Ttestforcontinuousvariables
orx²statisticsforcategorical
variables




































































9 Wasappropriatestatisticalanalysisused? Yes Logisticregressioncontrolling
forknownriskfactors.





































































9 Wasappropriatestatisticalanalysisused? Yes Coxproportionalhazards
regressionmodel.








































































9 Wasappropriatestatisticalanalysisused? Yes Unadjustedoddsratios(OR)and
confidenceintervals(CI)were
calculatedforeachvariable.

































































8 Wereoutcomesmeasuredinareliableway? Yes Alloutcomesweremeasured
usingvalidtoolsincludingKatz
etalADLscale,GDSandMMSE











































































9 Wasappropriatestatisticalanalysisused? Yes Univariateanalysisconductedto
examinerelationshipbetween
variabledataanddelirium
 Include? Yes 

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